Seattle Genetics reported $497.5M in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Acadia Pharmaceuticals ACAD:US $ 134.56M 19.1M
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Amgen AMGN:US $ 6594M 356M
Astellas Pharma 4503:JP Y 381791M 77921M
Bayer BAYN:GR € 12819M 1820M
Biogen BIIB:US $ 2589.1M 57.3M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Bristol Myers Squibb BMY:US $ 11887M 239M
Celldex Therapeutics CLDX:US $ 0.16M 0.01M
Clovis Oncology CLVS:US $ 32.14M 2.1M
Daiichi Sankyo 4568:JP Y 280317M 46392M
Eisai 4523:JP Y 184262M 6639M
Eli Lilly And LLY:US $ 6488M 1322M
Esperion Therapeutics ESPR:US $ 18.84M 5K
Exelixis EXEL:US $ 419.43M 63.45M
Genmab GEN:DC DK 3162M 1043M
Gilead Sciences GILD:US $ 6260M 330M
Glaxosmithkline GSK:US $ 6929M 2851M
GlaxoSmithKline GSK:LN 692900M 26100M
Immunogen IMGN:US $ 14.16M 23.92M
Insmed INSM:US $ 65.22M 12.11M
Karyopharm Therapeutics KPTI:US $ 39.68M 7.99M
Macrogenics MGNX:US $ 26.01M 14.91M
Merk MRK:US $ 14593M 1308M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Moderna Inc MRNA:US 4.75B 1.32B
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Takeda 4502:JP Y 972465M 99176M
Teva Pharmaceutical TEVA:IT 3.79B 125M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
Xencor XNCR:US $ 30.18M 55.32M
YTE INCY:US $ 911.4M 178.16M